ID   SNU-1-DOX
AC   CVCL_L042
DR   cancercelllines; CVCL_L042
DR   Wikidata; Q54955084
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu1154fs*12 (c.3457_3458insT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Lys860Asnfs*16 (c.2580delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0099 ! SNU-1
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
RX   PubMed=19956504; DOI=10.4143/crt.2005.37.1.1; PMCID=PMC2785416;
RA   Ku, Ja-Lok
RA   Park, Jae-Gahb
RT   "Biology of SNU cell lines.";
RL   Cancer Res. Treat. 37:1-19(2005).
//